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Objective: This study aimed to explore the structural aspects of bone quality in bone marrow lesions 
(BMLs) and subchondral cysts and to determine the association with structural progression in hip 
osteoarthritis (OA). 
Design: Six femoral heads from patients with OA at total hip arthroplasty and seven age-matched NoOA 
cadaveric controls, were scanned ex vivo by MRI to identify BMLs and cysts and evaluate cartilage 
volume, micro-CT imaged to quantitate the subchondral (plate and trabecular) bone microstructure in 
four regions (anterior superior [AS], anterior inferior [AI], posterior superior [PS] and posterior inferior 
[PI]) and imaged by synchrotron micro-CT to further assess bone vasculature and osteocyte lacunar.  
Results: BMLs and cysts in the OA femoral head were predominantly located in the anterior regions 
([AS] and [AI]). Overall intragroup differences in microstructure were not significant. In the OA group, 
AS and AI regions, followed by (PS) region contained the most structural alterations. Comparing OA 
to NoOA, we found that AS region of the OA group had significantly thicker subchondral bone plate 
(P < .0001, P < .05), thicker trabeculae (P < .0001, P < .05), and denser vascular canals (P < .05).  
Conclusion: In advanced hip OA microstructural deterioration of the subchondral bone was in 
association with the presence of BMLs and cysts. Therefore, the use of BMLs and subchondral bone 
cysts as MRI image-based biomarkers may provide information on the progressive state of OA within 








Osteoarthritis (OA) is a common musculoskeletal joint disease, predominantly affecting the knee, hand 
and hip, which results in pain and often renders mobility problems in individuals aged 50 and above 1-
4 .  Primary OA is the degeneration of an intact articular joint with no external influence while secondary 
OA is caused by certain factors such as obesity, genes and trauma, to mention a few. Symptoms of OA 
include general joint pain and groin pain specific to hip OA3, 5.  
Current treatments are limited to pain management drugs such as paracetamol and nonsteroidal anti-
inflammatory drugs (NSAIDs) in conjunction with lifestyle changes such as weight reduction and 
aquatic exercising with joint replacement surgery (arthroplasty) in late stages of the disease5-7. 
Excitingly, the research has shifted to the development of disease-modifying drugs, which can modify 
structural changes (subchondral bone remodelling and regrowing lost cartilage) in both the subchondral 
bone and cartilage respectively7. 
Pathogenesis of Osteoarthritis 
There are two opposing ideas about the pathogenesis of OA in the literature. One is the cartilage-driven 
OA, and the second is cartilage-subchondral bone (osteochondral) driven. For the cartilage-driven OA, 
studies have proposed injury to cartilage results in chondrocyte cluster formation, increased pro-
inflammatory factor release and proteoglycan and collagen network depletion as the disease progresses 
to late stage5, 8. In the osteochondral driven studies, there have been suggestions that cartilage matrix 
alteration and subchondral bone remodelling in response to biomechanical loading occurs at the same 
time9. The bone changes include subchondral bone plate thinning at the early stage of the disease4, 10 
and subsequent plate and trabecular bone thickening (sclerosis) in late or advanced stage4, 11. 
Additionally, the increased porosity, bone formation at the margins (osteophyte), subchondral cysts and 
bone marrow lesions formation, which appear to be sclerotic in comparison to unaffected areas are as a 
result of the increased trabecular thickness and bone volume fraction12. Concurrently, micro-damage in 
the form of micro-cracks occurring through the non-calcified cartilage, tidemark, calcified cartilage and 
the subchondral bone plate results in the growth of vascular tissues and nerve cells from the subchondral 
bone up via the micro-cracks into the articular cartilage5, 8. This suggests that there is an exchange of 
biochemical molecules between the bone and cartilage5, 8, 13, 14. However, hip subchondral bone 
microstructure (inclusive of bone microarchitecture, vascularity and microdamage), bone 
mineralisation as well as the molecules involved in the crosstalk is not entirely known8. 
Subchondral cyst and bone marrow lesion  
Over the years X-ray has been used predominantly (in the knee) as the primary clinical diagnostic tool 
for assessment of OA parameters such as joint space narrowing and subchondral cyst, but its lower 2-
dimensional resolution and irradiation has been its limitation15, 16. Later emergence of MRI as a 
diagnostic tool provided a better opportunity to establish an association between OA severity and 
progression and the disease parameters such as osteophyte formation, cartilage defects and loss as well 
as subchondral BMLs and cysts formation in the knee and hip OA17-20. However, despite its advantages, 
it is also limited by low resolution. Micro-CT is another imaging technique that has been used to 
evaluate subchondral bone density, osteophyte and subchondral cyst formation in both knee and hip 
OA. Despite micro-CT’s ability to analyse trabecular bone architecture in different 3-dimensional 
planes, it is also limited by higher irradiation13.  
Subchondral cysts defined as a zone of well-demarcated hyper signal located in the subchondral bone 
adjacent intimately to the articular cartilage and visible on the fluid-sensitive MR sequence and T1 low 
field MR sequence21. Many studies have suggested that cyst formation occurs through either fluid 
intrusion or bone resorption /contusion theory, which have been well described in the literature22-24. 
Cysts have been suggested to be associated with low bone mineralisation25 and shown to occur more 
often in the late stage of OA26. Subchondral cysts have also been found to be correlated with BMLs in 
the late stages of hip OA. 
BMLs are defined as irregular areas of increased signal intensity on the fluid-sensitive MR sequence 
and decreased intensity on T1 low field MR sequence27, 28. They characterised by oedema, fibrosis and 
necrosis at histopathology and contributed to the loss of articular cartilage and hip OA progression27, 28. 
Cross-sectional studies using MRI imaging techniques have found an association between cartilage 
defects and loss, and BMLs in both individuals with and without hip OA at the anterior and superior 
regions of the femoral head29. In the same study, the authors suggested that the more significant cartilage 
defect and the subsequent volume loss was found in individuals with hip OA compared to those without 
cartilage defects29. This finding suggested that MRI detected cartilage defects and BMLs might have 
occurred before individuals presenting with clinical OA symptoms such as pain.  Longitudinal studies 
have reported MRI images of hip OA to be correlated with histopathological BMLs and cysts 
assessment. It has been suggested that increased subchondral cyst size and number was significantly 
higher amongst OA patients. Moreover, increase BML, and subchondral cyst size is associated with 
worsening of hip pain 21, 28, 30-34. Taken together, clinical studies have provided invaluable information 
on the association of the cysts and BMLs with OA. However, the nature of these pathologies at tissue 
level is poorly understood35.  
In this study, we used advanced imaging modalities, micro-CT to quantify trabecular bone 
microarchitecture and synchrotron radiation micro-CT, a novel imaging technique with a higher spatial 
resolution while maintaining excellent signal to noise ratio and a higher power quantitative capability 
(in 3D)36, 37, to investigate bone quality ex vivo in femoral head subchondral bone areas where BMLs 
and cysts are found in hip OA. This technique will enable the visualisation of vascular canals and 
osteocyte lacunar, which have been suggested to interact with each other through dendritic processes 
and play a significant role in OA progression38, 39. We hypothesised that subchondral bone pathologies, 
BMLs and cysts, are indicative of different tissue processes and directly associated with different 
severity of structural degeneration within osteochondral tissue for hip OA. Thus, this study aimed to 
explore the structural aspect of bone quality in BMLs and subchondral cysts and determine the 





MATERIALS AND METHODS 
Study participants: Hip OA patients and Cadavers 
This project involved the use of 6 femoral heads from patients who had undergone total hip OA joint 
replacement surgery (South Australia (SA) Tissue Bank, Royal Adelaide Hospital). The control group 
comprised 7 cadaveric femoral heads obtained through the SA Tissue Bank, SA Pathology-Royal 
Adelaide Hospital Mortuary, with no previous history of bone or joint disease (Paget’s disease, 
malignant tumours, avascular necrosis, rheumatoid arthritis), or medication that may have affected bone 
metabolism. 
Both experimental and control groups of specimens comprised of an equal number of females and males 
aged >50 years. Inclusion criteria for the OA group were; individuals with confirmed radiographic OA 
with severe symptomatic disabilities. Exclusion criteria were individuals with OA due to trauma or 
rheumatoid arthritis, osteoporosis, as well as metabolic bone diseases. 
Written consent was obtained for all participants, and initial approval for the study was received from 
the Human Research Ethics Committee at the Royal Adelaide Hospital and The University of Adelaide, 
South Australia, under the Declaration of Helsinki 1975 
Imaging techniques 
Magnetic Resonance Imaging (MRI) assessment 
To detect subchondral bone pathologies (BMLs and subchondral cysts), each femoral head was imaged 
using MRI ex vivo in an 8-channel wrist coil (3T MRI Siemens TRIO, Royal Adelaide Hospital, 
Adelaide) where two clinically relevant sequences were used. These include fat-suppressed fast spin-
echo proton density-weighted (PDFS), and T1 –weighted40, 41.  
A BML as seen in (Fig 1) was defined as a zone of altered signal intensity seen on PDFS, and T1 
weighted sequences in the bone marrow, located immediately beneath the articular cartilage and visible 
on at least two consecutive slices40-43. 
 
Fig 1. MRI of the femoral head (PDFS/T1 weighted view) of a 69-year-old male hip OA patient taken 
ex-vivo (post hip replacement surgery). BML (within orange oval shape) is visualised as an ill-defined 
area of hyper-intense signal in PDFS-weighted sequences (A). In T1-weighted sequences the BML 
appears as a hypo-intense signal (B).  
A subchondral cyst (Fig 2) was defined as a well-demarcated hyper-signal. 
 
Fig 2. MRI of the femoral head (PDFS/T1-weighted view) of a 48-year-old male hip OA patient taken 
ex vivo (post hip replacement surgery). In PDFS-weighted sequences, a cyst (within yellow oval shape) 
appears as a well-demarcated hyper-signal. In T1-weighted sequences, cysts are visualised as a well-
demarcated hypo-signal.  
Three-dimensional (3D) sequences were used to map the frequency and location of bone cysts and 
BMLs. Cartilage volume was obtained from MRI images40. 
MR images were used to obtain cartilage volume data. Cartilage volume was assessed using the MRI 
reading software HOROS (Purview, Annapolis, MD USA), and the external contour around the 
cartilage boundaries of the femoral head was manually marked on the PDFS coronal images, 
additionally then the automatic volume rendering function was used to calculate the volume in cm3 (Fig 
3). Cyst and BML volume were assessed using Materialised Mimics Research software (Materialise 
NV, Belgium), and the area defined as cyst and BML was masked manually on the PDFS coronal 
images (Fig 4). Automatic volume rendering function was used to calculate the volume in mm3.    
 
Fig 3. MRI of the femoral head (A-coronal view) of a 50-year-old female hip OA patient taken (post 
hip replacement surgery). (A) yellow external contour around the cartilage boundaries of the femoral 
head. (B) 3D image generated via automatic volume rendering of the cartilage.   
 
Fig 4. MRI 3D model of femoral head with BML (yellow) and cyst (red). 
Miro-computed tomography (micro-CT) imaging 
To analyse the microstructure of the subchondral bone in the whole femoral head, each specimen was 
scanned at a high spatial resolution by micro-CT (Skyscan 1276; Skyscan-Brucker Belgium) at 
Adelaide Microscopy, The University of Adelaide. Scanner settings were:20.5 µm isotropic pixel size, 
source voltage 100kVp, current 200µA, rotation step 0.8˚, 180˚ rotation, exposure time 700 ms, 3 frames 
averaging. An aluminium-copper filter 1.0mm thick was used for beam hardening artefact reduction. 
Each scan was performed in four consecutive automated steps, imaging one-fourth of the specimen. For 
each femoral head, this produced a total of 3305 X-ray projection images (826 projection per step), each 
image 3872 × 3872 pixels in size, saved in 16-bit Tiff format, generating a projection dataset of 24.3 
GB, scan duration ̴ 4 h. The cross images were then reconstructed using a filtered back-projection 
algorithm (NRecon software, v2.0.4.2, Skyscan-Bruker). The reconstructed images were binarized 
using adaptive thresholding. The adaptive threshold value was the average of threshold values 
determined from the histograms of a subset of six representatives (three from each group) specimens 
and then applied consistently to all the specimens41. 
 
 
Micro-CT Image processing 
Femoral head images were manually realigned using Data viewer to match its anatomical representation 
(left and right) in humans. Realigned images were opened in CTAn analyser software (v.1.18.8.0+ 64 
bits) to determine the region of interest. A 4 cylindric region of interest (ROI, size 10×10mm) was 
selected from anterior superior (AS), anterior inferior (AI), posterior superior (PS) and posterior inferior 
(PI) aspect of the femoral head (Fig 5) and saved as a volume of interest (VOI). For each region of 
interest, the plate was split from trabecular bone and was evaluated. Plate thickness was manually 
evaluated, while the remaining parameters were performed separately.  
 
Fig 5. Location of bone cores. The OA bone cores were sampled in areas with and without cartilage 
according to anatomical locations AS, AI, PS and PI.  
Micro-CT morphometric evaluation  
Subchondral plate microstructure parameters determined included plate thickness (Pl.Th), porosity 
(Pl.Po) and percent bone volume (BV/TV), while subchondral trabeculae parameters included: 
trabecular bone volume (BV/TV,%), which was calculated as the voxels segmented as a bone within 
VOI, divided by the total number of voxels; trabecular number (Tb.N 1/mm), describing trabeculae per 
unit length; trabecular thickness (Tb.Th, mm), describing the average 3D thickness of the trabeculae, 
trabecular separation (Tb.Sp, mm), describing a 3D measure of the mean distance between the 
trabeculae, structural model index (SMI), describing the measure of predominant shapes in the plate-
like/rod-like structure; trabecular bone pattern factor (Tb.Pf), describing a quantitative ratio of inter-
trabecular connectivity;  and degree of anisotropy (DA) that depicts the orientation of bone 
microarchitecture.  
Synchrotron radiation computed tomography (Synchrotron micro-CT) imaging 
Synchrotron tomographic X-ray experiments were carried out at the X02DA TOMCAT beamline of the 
Swiss Light Source (SLS) facility at Paul Scherrer Institute (PSI) Switzerland. A monochromatic beam 
with energy 21keV was used to acquire tomography scans. The X-ray imaging system consisted of a 
microscope (Optique Peter) with 4× magnification objective and LuAG:CE µm scintillator coupled to 
a pco.edge 5.5 detector with a pixel size of 1.63µm and filed of view 4.2×3.5 mm2. For each sample, 
1800 projections uniformly distributed over 180 degrees were taken with 120ms exposure each. 
Tomographic reconstructions were performed on the TOMCAT cluster44 using phase retrieval method 
from a single defaced image45 and GridRec algorithm 46. Final reconstructed images were saved as 16-
bit tiff image stacks. Through the synchrotron radiation X-ray for micro-CT, beam hardening artefact 
and noise was almost eliminated, and high-quality quantitative assessment of the bone quality of the 
areas in proximity was obtained.  Moreover, the 3D organisation of the vascular canal network and 
osteocyte lacunae was visualised, counted and measured using CTAn.  
Synchrotron micro-CT image processing  
We used CTAn analyser software for image processing. An (Otsu) thresholding in 3D space with a 
radius of 3 methods was applied to the reconstructed trabecular bone to segment the mineralised tissue 
and non-mineralized structures47. Noise (small objects) which did not belong to the bone after 
thresholding was removed by running sweep function in 3D, removing objects less than 1000 pixels. 
Afterwards, both blood vessels (open pores) and osteocyte lacunae (closed pores) were closed in the 
trabecular bone. Thus, it allowed the creation of the region of interest (ROI). A few large pores with an 
area less than 1800 pixels that remained in the trabecular selection were removed using a 2D despeckled 
filter in CTAn. Hence, this created ROI for trabecular bone. Subsequently, porosity analysis was 
performed using the 3D analysis plugin in custom processing. Closed pores/objects volume ranging 
from 30-2000µm3 were considered as osteocyte lacunae (Fig 6.A), and open pores/object 
volume >2000µm3 were characterised as vascular canals (Fig 6.B), based on previous studies47. 
 
Fig 6. A-B showing 3D models of vascular canals and osteocyte lacunae respectively. 
Synchrotron micro-CT 3D morphometric evaluation 
Vascular canal parameters quantitatively measured included: Average canal number (ACa.N), canal 
density (Ca.Dn) which was calculated as Ca.N/BV, canal volume (Ca.V), the ratio of canal volume 
which was calculated as Ca.V/BV, canal surface (Ca.S), the ratio of canal surface which was calculated 
as Ca.S/BV and vascular canal diameter. 
Osteocyte lacunar parameters were grouped into general, morphological and shape descriptive. Lacunar 
density (N.Lc/BV) calculated as the number of lacunae over bone volume. Morphological parameters 
consisted of osteocyte volume and osteocyte surface. Shape descriptive parameters were sphericity 
(Sph), which is the ratio of the smallest to largest radii and is a measure of lacunar stretch. For complex, 
non-spherical objects the surface area of the volume-equivalent sphere will be much smaller than the 
particle surface area; hence Sph will be lower. Sph maximum possible value is 1, which would be 
obtained for a sphere. Sauter diameter is the diameter of the sphere that would have the same volume-
to-surface (V/S) ratio as a discreet 3D object. Lacunar orientation theta and phi denote the orientation 
lacunar based on specific angles. For angles between 0-22.5, 22.5-67.5 and 67.5-90, theta and phi will 
be transverse radial, transverse oblique/ oblique, longitudinal radial/ circumferential respectively.  
Synchrotron micro-CT images of each sample were reconstructed into 3D computer models (Fig 7) 
using image processing software (CTAn plus CTVox v.2.3.2.0. 64 bits).  
 
Fig 7. Typical 3D images of A- trabecular bone, B- osteocyte lacunae, C-vascular canals and D-
combination of the three components obtained with synchrotron imaging 
 
Statistical Analysis 
All data sets were analysed by the Shapiro-Wilk test to determine the normality of the data distribution. 
For between-group (NoOA vs OA) comparisons, where variables were continuous normally distributed, 
an unpaired, two-tailed Student’s t-test was used while for continuous non-normally distributed 
variables; an unpaired, two-tailed Mann-Whitney test was used. Two-way ANOVA (mixed model) with 
the Turkey test was used for multiple comparisons.  
The critical value for statistical significance was chosen as P<0.05. These analyses were performed 
using the GraphPad Prism software (v. 8.4.2, Inc., USA). 
RESULTS  
Population characteristics 
Demographic characteristics and MRI data of participating individuals are summarised in Table 1.  
MRI Assessment 
MRI assessment showed that amongst the 7 subjects in OA-group, 6 (85.71%) contained pathologies 
(BMLs & cysts) detected by PDFS and T1-weighted sequences in the anterior regions of the femoral 
head while 1 (14.28%) had no MRI pathology and was excluded. In the NoOA group, 7 (87.50%) had 
no pathologies, while 1 (12.50%) was excluded based on finding malignant-like pathological changes 
identified by MRI. The OA-group cartilage volume ranged from 2-5mm3 with an average of 3.86mm3, 
whereas the NoOA group cartilage volume ranged from 3-6mm3 with an average of 5.08mm3. Cyst 
number ranged from 2-12 with an average of 5.3, and Cyst volume ranged from 11-558mm3 with an 
average of 270.80mm3. BML number ranged from 3-13 with an average of 7 and BML volume ranged 





Patients’ demographic and MRI data. 
 NoOA (n= 7) OA (n= 6) P value 
Age (years) 50.33 ± 5.51 64.43 ± 12.74 .11 
Male (%) 3(42.86) 3(50) NA 
Female (%) 4(57.14) 3(50) NA 
Cartilage volume 
(mm3) 
5.08±0.77 3.86 ± 1.17 .05 
Cyst Number 0 5.33 ± 4.46 NA 
Cyst Volume (mm3) NA 222.6(51.39-533.9) NA 
BML Number 0 7.00 ± 3.65 NA 
BML Volume (mm3) NA 801.2(432.4-4080) NA 












Out of the 6 OA group, 1 was excluded due to unknown pathology, and the remaining 5 were assessed. 
Similarly, the NoOA group were assessed for structural changes or reduction in bone quality. In the OA 
group, femoral head areas containing BMLs and cyst were compared to corresponding anatomically 
matched areas in NoOA femoral heads without BMLs and cysts.  
Values for percent bone volume and that of plate porosity in PI were excluded due to large osteophyte 
merging with the plate. Likewise, values for plate thickness in AI, PS and PI regions were excluded. 
Hence the further reduction in number for those regions. 
The results of the subchondral bone plate are illustrated in Fig 8 and 9. There was no significant 
intragroup variability in mean plate thickness, plate porosity and plate percent bone volume within 
NoOA and OA groups (Fig.8). However, there was significant in plate thickness, plate porosity and 
percent bone in some subregions (mostly AS and PS) between NoOA and OA groups (Fig.9).   
In subchondral bone trabeculae, there was significant intragroup variability detected in mean percent 
bone volume between subregions of OA and no significant difference in NoOA Fig 10. Subchondral 
trabecular bone intergroup results are illustrated in Fig 11. The difference in subchondral trabecular 
bone morphological and topological parameters such as BV/TV, Tb.Th, Tb.Pf, FD and DA were 
statistically significant between NoOA and OA samples for AS and AI subregions, respectively (P < 
0.0001)  (Fig 11 & 12). 
Subchondral bone plate intragroup variability 
 
Fig 8. Intragroup variability. Two-way ANOVA results of plate parameters. BV/TV, Pl.Th and T.Po is 
with non-significant interaction. Data shown as mean ± standard deviation. 




Fig 9. Intergroup variability. Unpaired t-test results of plate parameters. Data shown as mean ± standard 
deviation, Comparison P value *P < 0.05, **P < 0.0001. BV/TV, Pl.Th,and T.Po are with non-significant 
difference at AI. Pl.Th is with non-significant difference at PS. BV/TV, Pl.Th and T.Po is with non-






Trabecular bone intragroup variability  
 
Fig 10. Intragroup variability. Two-way ANOVA results of trabecular bone. Data shown as mean ± 





Trabecular bone intergroup variability 
 
 
Fig 11. Difference between groups. Unpaired t-test results of trabecular bone parameters in anterior 
superior, anterior inferior, posterior superior and posterior inferior regions. Data shown as mean ± 
standard deviation. Comparison P value *P < 0.05, **P < 0.001, ***P <0.0001. 
Trabecular bone  
 
Fig 12. Micro-CT 3D models of trabecular bone for NoOA (A-B) and OA (C-D) in AS region with 
higher BV/TV and thickened trabecular and two cysts marked by black pattern.  
Synchrotron micro-CT assessment 
First, we performed an intragroup analysis to investigate if there was a difference in vascular canal 
parameters between anatomical regions (Fig 13). We did not find the statistically significant difference 
within NoOA, but in OA, R.Vas.S/BV was different between NoOA and OA subregions. Then we 
compared anatomical regions between OA and NoOA (Fig 14). In the AS region, we found that Vas.Dn 
is increased in OA group. In AI region, Vas.V and Vas.Dm were significantly increased in OA 
compared to NoOA group (P <0.04). In PS region, we did not find any difference between OA and 
NoOA groups, but there was a significant decrease in Vas.V in OA compared to NoOA (Fig 14). 
Intragroup analysis indicated that there is no significant difference in osteocyte lacunar morphological 
and topological parameters between regions in both NoOA and OA groups (Fig 15). Additionally 
comparing regions between NoOA and OA, no statistically significant difference was found except 
La.Dn (P = 0.03) in PS region (Fig 16).  
Vascular canal intragroup variability 
 
Fig 13. Intragroup variability. Two-way ANOVA results of vascular canal parameters. Data shown as 
mean ± standard deviation, Comparison P value *P < 0.05. Vas.Dn, Vas.V, R.Vas.V/BV, Vas.S and 








Fig 14. Difference between groups. Unpaired t-test results of vascular canal parameters in anterior 
superior, anterior inferior, posterior superior and posterior inferior regions. Data shown as mean ± 
standard deviation. Comparison P value *P < 0.05. 
Osteocyte lacunar intragroup variability 
 
Fig 15. Intragroup variability. Two-way ANOVA results of osteocyte lacunar parameters. All 













Fig 16. Difference between groups. Unpaired t-test results of osteocyte lacunar parameters in anterior 
superior, anterior inferior, posterior superior and posterior inferior regions. Data shown as mean ± 
standard deviation. Comparison P value *P < 0.05. 



























Fig 17. Synchrotron micro-CT 3D models showing trabecular bone white and transparent (A-P), 
vascular canals (red) (A-P) and osteocyte lacunar for NoOA (green - B, F, J & N) and OA (yellow – D, 







This is the first study describing comprehensively subchondral bone microstructure (subchondral plate 
and trabeculae), vascularisation of bone matrix in 4 different anatomical regions and osteocyte lacunae 
properties and comparing it between NoOA and OA. We observed that subchondral bone pathologies 
visualised by MRI (BMLs and cysts) occurred mainly in bone (anterior regions) beneath areas where 
cartilage has depleted, resulting in changes in the plate and trabecular bone micro-architecture. These 
data suggest that there is an association between subchondral bone alterations and the presence of BMLs 
and cysts in the OA group. However, there was no significant difference in NoOA group for parameters 
describing subchondral bone microstructure.  
Structural differences in the subchondral bone plate and trabeculae in hip OA patients 
Most of the microstructural differences were found in the anterior regions of the femoral head known 
to be associated with lower bone quality due to higher peak forces and the presence of pathologies48-51.  
Subchondral bone plate 
Higher subchondral bone volume fraction and plate thickness in the OA group suggested hip OA was 
in the late stage, which is in line with previous studies25, 52, 53. These bone changes seem to signify the 
adaptive mechanism (modelling and remodelling) of subchondral bone architecture as a result of 
cartilage loss and the impact of mechanical loading or biomechanical influence reported in previous 
studies54-56.  With increasing plate thickness, total plate porosity in the OA group decreased compared 
with NoOA, which contradicts a study by Li et al.53 who found increased plate porosity with increased 
plate thickness in advanced OA. The increased porosity in NoOA group could be due to regular bone 
changes associated with aging, which was reported by a study investigating age-related changes in 
human trabecular microarchitecture57. 
Subchondral trabeculae 
Within the OA group, the AS region had increased bone volume compared to the PS region. However, 
comparing NoOA and OA, there was a 14% increase in mean bone volume fraction and trabecular bone 
thickness in OA was twice that of NoOA in two regions (AS and AI). These data are supported by 
previous studies that found increased BV/TV and Tb.Th in corresponding femoral head locations26, 51, 
53 to be associated with large cyst number and volume58. Furthermore, higher cyst number and volume 
was associated with future joint replacement59, 60.  Some studies found that multiple subchondral cysts, 
which are sometimes colocalised with subchondral BMLs61 occurring at the superior weight-bearing 
surface of the femoral head62 were associated with higher BV/TV and Tb.Th and related to an increase 
in bone density and hardening (sclerosis) 11, 59. Chiba et al.,59 suggested that each cyst caused reactive 
bone formation itself, and the multiple formations of such reactive bone lead to bone sclerosis or perhaps 
cyst formation changes the distribution of mechanical load in the subchondral bone resulting in more 
stress on the remaining trabecular bone followed by bone sclerosis59. However, the mechanism of the 
subchondral cyst and sclerosis formation is still unclear11, 59 
Trabecular number and separation did not increase between OA and NoOA groups in all regions. 
Trabecular bone structures were more plate-like due to low structure model index and were less 
connected as a result of higher mean value of the trabecular pattern factor, in the AI region.  What is 
more, the degree of anisotropy in trabeculae was higher in AI for NoOA compared to OA group, because 
it has been suggested to be more sensitive to aging and trabecular bone changes57. Increased fractal 
dimension in OA suggests trabecular bone surface was less smooth associated with advance OA63. 
Regarding BMLs, it is also believed to occur in regions with the highest loading. BMLs in the anterior 
region (area with the highest pressure) of the femoral head was associated with cartilage volume loss64 
and subsequent sclerosis29, 65. This seems to support the altered bone microarchitecture found in the 
anterior region of this study. Studies have suggested that BMLs may be present before clinical 
symptoms (pain), and add that unresolved BMLs coupled with persistent joint loading results in 
increased fibrosis and vascularity65, 66. However, little is known about the underlying mechanism of 
BMLs formation50, 66.   
This study explored both BMLs and cysts in the OA femoral head and found they occurred at anterior 
regions, where the aforementioned subchondral bone alterations were recorded. Thus, suggesting its 
possible role in bone sclerosis reported in other studies26.    
Vascular canal and osteocyte lacunar in trabeculae  
Vascular canal 
The changes in OA vascular canals in this study likely suggest its role in subchondral bone remodelling, 
evidently seen in the subchondral plate and trabecular bone volume and thickness. These data are 
supported by previous studies which found increased angiogenesis in the osteochondral unit in OA 
patients with subchondral pathology39, 40. Subchondral angiogenesis has also been shown to be closely 
associated with nerve growth, which is responsible for the manifestation of the clinical symptoms (pain) 
in individuals with pathology (BMLs and cysts) in hip OA67. The decrease in vascular canal volume in 
the PI region may suggest lower remodelling in the region. However, there is lack of data on the regional 
variation of vascular canal in hip OA. Therefore, comparison to other studies could not be made. Tiede 
et al.38 have reported the intimate connection of vascular canals with osteocyte lacunar through dendritic 













Osteocytes represent about 90% of bone cells and are located in lacunae (space), interconnected with 
other osteocytes to form a network in the bone matrix. They are believed to act as mechanosensory cells, 
which translate mechanical force (compressive) into biochemical signals via dendritic processes and 
coordinate the osteoclasts and osteoblasts for bone resorption and formation respectively37, 38.  Human 
bone studies have found a correlation between dense osteocyte network and more desirable bone tissue 
quality68. Moreover, robust osteocyte network has been suggested to be vital in the initiation of 
remodelling responses and opposing structural damage to uphold healthy and mechanically resilient 
bone69. This is in line with studies that suggest differences in lacunar properties are linked with the 
functional adaptation of bone70-72. In this current study, it cannot be excluded that the small sample size 
might have resulted in the parameters not reaching statistical significance. Another reason could be 
differences in methodology in the evaluation of osteocyte lacunar parameters. For instance, some of 
these studies were performed in animals using 2D analysis, and even those performed in humans had 
samples collected from different anatomical regions believed to have different osteocyte distribution, 
shape and size73. All of which could make the increase in lacunar density in the OA group at the PI 
region significantly weak even though it might be in line with studies reported in Mader et al.,73 study.   
The strength of this cross-sectional study relates to the comprehensive analysis of the subchondral bone 
microarchitecture using micro-CT coupled with a novel higher spatial resolution synchrotron micro-
CT. There are several limitations to this study. Firstly, the small sample size was used in this study 
because some images had unknown pathologies, which led to the exclusion of these specimens and a 
further reduction in sample size. Thus, it limits the generality of the results. Therefore, a larger sample 
size will be required in future studies to achieve the aims of this study. Secondly, due to the cross-
sectional design of this study, the genesis of BMLs and cysts were not identified, and the early stage of 
the disease could not be confirmed in the subchondral bone structure. Moreover, localised cartilage 
volume was not calculated for each anatomical region, hence, making it difficult to determine whether 
pathology presence was secondary to cartilage volume loss or vice versa. What is more, the 
quantification of osteocyte lacunae did not consider the presence/absence of viable and non-viable 
osteocytes.  
In conclusion, this study showed that degenerated cartilage or, the presence of MRI bone pathology 
BML or cyst or both might contribute to alteration in subchondral bone microarchitecture in hip OA 
and drive the disease progression.  Hence, BMLs and cysts could be monitored with advanced MRI 
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